• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Former MiMedx COO given same prison sentence as CEO for fraud scheme

Former MiMedx COO given same prison sentence as CEO for fraud scheme

February 24, 2021 By Sean Whooley

mimedx logoEx-MiMedx chief operating officer William Taylor was sentenced to one year in prison for his involvement in a fraud scheme.

Taylor’s sentence matches the one handed down to former CEO Parker Petit yesterday. Both were convicted of crimes related to the fraud schemes involving distributors. In addition to his one-year prison term, Taylor will have to pay a $250,000 fine, according to a news release from the U.S. Attorney’s Office in the Southern District of New York.

In November 2020, a Manhattan jury found that Petit, 81, and Taylor, 52, had entered into undisclosed side arrangements with five distributors. These side arrangements allowed distributors to return product to Marietta, Ga.-based MiMedx or conditioned distributors’ payment obligations on sales to end-users, the government charged.

Petit was convicted of securities fraud and Taylor, 52, was convicted of conspiracy to commit securities fraud, to make false statements in SEC filings and to mislead the conduct of audits. Both received one-year sentences despite the securities fraud count for Petit carrying a maximum sentence of 20 years in prison, while the conspiracy count against Taylor could have been up to a five-year maximum.

The two executives were ousted from MiMedx for cause after an independent probe into its revenue recognition forced the company to restate its earnings going back to 2012. The company was alleged to have misstated revenues and attempted to cover up misconduct from 2013 to 2017, prematurely recognizing revenue from sales to distributors and exaggerating revenue growth.

According to the SEC, Petit and Taylor covered up the scheme for years, even after the company’s former controller raised concerns over the accounting scheme. Additional allegations included misleading outside auditors, members of the company’s audit committee and outside lawyers inquiring about the transactions.

Federal prosecutors claimed that Petit’s and Taylor’s alleged manipulation of MiMedx’s revenue caused MiMedx to report 2015 annual revenue that was fraudulently inflated by approximately $9.5 million, or about 5%. MiMedx had previously agreed to pay $1.5 million to settle federal charges that it and three former top executives allegedly defrauded investors.

“William Taylor and his co-defendant used secret agreements and corrupt financial inducements to materially misstate quarterly and annual sales revenue of MiMedx,” Manhattan U.S. Attorney Audrey Strauss said in the release. “They deceived the SEC, auditors, and the investing public.  Now Taylor, like Parker Petit yesterday, has been sentenced to prison for his crimes.”

Filed Under: Business/Financial News, Featured, Legal News Tagged With: MiMedx Group Inc.

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy